Noemi Aiezza

437 total citations
10 papers, 253 citations indexed

About

Noemi Aiezza is a scholar working on Molecular Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Noemi Aiezza has authored 10 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Medicine, 4 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Noemi Aiezza's work include Antibiotic Resistance in Bacteria (8 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Antibiotic Use and Resistance (3 papers). Noemi Aiezza is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Antibiotic Use and Resistance (3 papers). Noemi Aiezza collaborates with scholars based in Italy. Noemi Aiezza's co-authors include Gian María Rossolini, Vincenzo Di Pilato, Tommaso Giani, Alberto Antonelli, Luigi Principe, Francesco Luzzaro, Ilaria Baccani, Eva Maria Parisio, Cesira Giordano and Simona Barnini and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Frontiers in Immunology.

In The Last Decade

Noemi Aiezza

10 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noemi Aiezza Italy 7 193 75 63 54 50 10 253
Sophie Loeffert France 6 186 1.0× 83 1.1× 54 0.9× 88 1.6× 48 1.0× 8 259
Anaëlle Muggeo France 10 157 0.8× 39 0.5× 50 0.8× 52 1.0× 24 0.5× 23 271
E.Yu. Skleenova Russia 7 202 1.0× 44 0.6× 27 0.4× 90 1.7× 58 1.2× 13 239
Huangdu Hu China 10 204 1.1× 47 0.6× 28 0.4× 54 1.0× 37 0.7× 24 247
Temenuga Stoeva Bulgaria 10 217 1.1× 39 0.5× 40 0.6× 65 1.2× 50 1.0× 41 289
Xiuyu Xu China 11 192 1.0× 67 0.9× 52 0.8× 60 1.1× 48 1.0× 25 371
Efrat Khabra Israel 7 198 1.0× 33 0.4× 62 1.0× 47 0.9× 57 1.1× 8 245
Ali F. Aboklaish United Kingdom 8 170 0.9× 75 1.0× 25 0.4× 52 1.0× 41 0.8× 13 282
Daniela Maria Palma Italy 6 248 1.3× 57 0.8× 36 0.6× 52 1.0× 55 1.1× 6 270
Antonio Moreno‐Flores Spain 5 170 0.9× 43 0.6× 52 0.8× 59 1.1× 18 0.4× 10 228

Countries citing papers authored by Noemi Aiezza

Since Specialization
Citations

This map shows the geographic impact of Noemi Aiezza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noemi Aiezza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noemi Aiezza more than expected).

Fields of papers citing papers by Noemi Aiezza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noemi Aiezza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noemi Aiezza. The network helps show where Noemi Aiezza may publish in the future.

Co-authorship network of co-authors of Noemi Aiezza

This figure shows the co-authorship network connecting the top 25 collaborators of Noemi Aiezza. A scholar is included among the top collaborators of Noemi Aiezza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noemi Aiezza. Noemi Aiezza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Riccobono, Eleonora, Noemi Aiezza, Claudia Niccolai, Tommaso Giani, & Gian María Rossolini. (2023). Evaluation of VITEK® 2 AST cards (AST-N376 and AST-N397) for susceptibility testing of challenging Gram negatives. Diagnostic Microbiology and Infectious Disease. 107(2). 116032–116032. 1 indexed citations
2.
Aiezza, Noemi, Alberto Antonelli, Marco Coppi, et al.. (2023). Up-regulation of resident chromosomal fosB gene expression: a novel mechanism of acquired fosfomycin resistance in MRSA. Journal of Antimicrobial Chemotherapy. 78(7). 1599–1605. 3 indexed citations
3.
4.
Pilato, Vincenzo Di, Lucia Henrici De Angelis, Noemi Aiezza, et al.. (2022). Resistome and virulome accretion in an NDM-1-producing ST147 sublineage of Klebsiella pneumoniae associated with an outbreak in Tuscany, Italy: a genotypic and phenotypic characterisation. The Lancet Microbe. 3(3). e224–e234. 62 indexed citations
5.
Mazzoni, Alessio, Anna Vanni, Michele Spinicci, et al.. (2022). SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron. Frontiers in Immunology. 13. 801431–801431. 31 indexed citations
6.
Maggio, Tiziana Di, Noemi Aiezza, Alberto Antonelli, et al.. (2022). Activity of fosfomycin/colistin combinations against planktonic and biofilm Gram-negative pathogens. Journal of Antimicrobial Chemotherapy. 77(8). 2199–2208. 22 indexed citations
7.
Coppi, Marco, Noemi Aiezza, Ilaria Baccani, et al.. (2021). Rapid screening for SARS-CoV-2 VOC-Alpha (202012/01, B.1.1.7) using the Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay. International Journal of Infectious Diseases. 113. 207–209. 6 indexed citations
8.
Pilato, Vincenzo Di, Noemi Aiezza, Alberto Antonelli, et al.. (2020). KPC-53, a KPC-3 Variant of Clinical Origin Associated with Reduced Susceptibility to Ceftazidime-Avibactam. Antimicrobial Agents and Chemotherapy. 65(1). 23 indexed citations
9.
Falcone, Marco, Giusy Tiseo, Alberto Antonelli, et al.. (2020). Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase–Producing Enterobacterales During a Regional Outbreak. Open Forum Infectious Diseases. 7(2). ofaa011–ofaa011. 51 indexed citations
10.
Cannatelli, Antonio, Tommaso Giani, Noemi Aiezza, et al.. (2017). An allelic variant of the PmrB sensor kinase responsible for colistin resistance in an Escherichia coli strain of clinical origin. Scientific Reports. 7(1). 5071–5071. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophie Loeffert Breakdown of academic impact, for papers by Anaëlle Muggeo Breakdown of academic impact, for papers by E.Yu. Skleenova Breakdown of academic impact, for papers by Huangdu Hu Breakdown of academic impact, for papers by Temenuga Stoeva Breakdown of academic impact, for papers by Xiuyu Xu Breakdown of academic impact, for papers by Efrat Khabra Breakdown of academic impact, for papers by Ali F. Aboklaish Breakdown of academic impact, for papers by Daniela Maria Palma Breakdown of academic impact, for papers by Antonio Moreno‐Flores
Rankless by CCL
2026